Equities research analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report released on Saturday. The firm set a “hold” rating on the stock.
Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.
View Our Latest Analysis on MLSS
Milestone Scientific Stock Up 5.4 %
Insider Activity
In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 24.75% of the company’s stock.
Hedge Funds Weigh In On Milestone Scientific
A number of institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares in the last quarter. World Investment Advisors LLC purchased a new position in Milestone Scientific during the third quarter valued at approximately $91,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific in the third quarter worth approximately $48,000. 5.79% of the stock is owned by institutional investors.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- Buy P&G Now, Before It Sets A New All-Time High
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- With Risk Tolerance, One Size Does Not Fit All
- How AI Implementation Could Help MongoDB Roar Back in 2025
- The How And Why of Investing in Oil Stocks
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.